Cancers, Vol. 12, Pages 896: Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch ® and ISET
Cancers, Vol. 12, Pages 896: Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET
Cancers doi: 10.3390/cancers12040896
Authors:
Tamminga
Andree
Hiltermann
Jayat
Schuuring
van den Bos
Spierings
Lansdorp
Timens
Terstappen
Groen
Circulating tumor cells (CTCs) detected by CellSearch are prognostic in non-small-cell lung cancer (NSCLC), but rarely found. CTCs can be extracted from the blood together with mononuclear cell populations by diagnostic leukapheresis (DLA), therefore concentrating them. However, CellSearch can only process limited DLA volumes (≈2 mL). Therefore, we established a protocol to enumerate CTCs in DLA products with Isolation by SizE of Tumor cells (ISET), and compared CTC counts between CellSearch® and ISET. DLA was performed in NSCLC patients who started a new therapy. With an adapted protocol, ISET could process 10 mL of DLA. CellSearch detected CTCs in a volume equaling 2 × 108 leukocytes (mean 2 mL). CTC counts per mL were compared. Furthermore, the live cell protocol of ISET was tested in eight patients. ISET successfully processed all DLA products—16 with the fixed cell protocol and 8 with the live cell protocol. In total, 10–20 mL of DLA was processed. ISET detected CTCs in 88% (14/16), compared to 69% (11/16, p < 0.05) with CellSearch. ISET al...
Source: Cancers - Category: Cancer & Oncology Authors: Tamminga Andree Hiltermann Jayat Schuuring van den Bos Spierings Lansdorp Timens Terstappen Groen Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Lung Cancer | Non-Small Cell Lung Cancer